Presystemic Elimination
Presystemic Elimination is a pharmacokinetic phenomenon characterized by the metabolic degradation of an administered drug during its initial passage through the liver prior to entering the systemic circulation, thereby reducing its bioavailability.
41
Publications
1.7K
Citations
172
Authors
50
Institutions
Publications per year
2017–2026
1
41
Systemic delivery of peptides and proteins across absorptive mucosae.
Amyn Sayani, Yie W. Chien · PubMed · 1996 · 161 citations
Felodipine kinetics in healthy men
Boo Edgar, C G Regårdh, G. Johnsson et al. · Clinical Pharmacology & Therapeutics · 1985 · 111 citations
1–5 of 41
172
2
h-index
2
h-index
2
h-index
Rutgers, The State University of New Jersey, United States
2 publications · 255 citations
2
h-index
2
h-index
1–5 of 172
50
National Cancer Institute
Bethesda, United States
2 h-index
2 publications
36 citations
Rutgers, The State University of New Jersey
New Brunswick, United States
2 h-index
3 publications
349 citations

Universidad de Montevideo
Montevideo, Uruguay
1 h-index
3 publications
48 citations

University of Georgia
Athens, United States
1 h-index
3 publications
72 citations
Johannes Gutenberg University Mainz
Mainz, Germany
1 h-index
7 publications
420 citations
National Institute for Public Health and the Environment
De Bilt, The Netherlands
1 h-index
3 publications
132 citations
Tokyo University of Pharmacy and Life Sciences
Hachiōji, Japan
1 h-index
1 publications
36 citations
University Hospital Bonn
Bonn, Germany
1 h-index
1 publications
17 citations
1–8 of 50
Repository · 6 publications · 342 citations
6
h-index
4 publications · 77 citations
4
h-index
CPT · 3 publications · 196 citations
3
h-index
BJCP · 3 publications · 57 citations
3
h-index
3 publications · 143 citations
3
h-index
1–5